Ozempic, Tirzepatide, and the World of Anti-Obesity Medications (AOM)
Semaglutide, commonly referred to as Ozempic[i], falls into drugs categories known as GLP-1 or Glucagon-like peptide-1 (GLP-1) agonists. Tirzepatide, commonly referred to at the brand Mounjaro[ii], falls into a dual agonist category which contain both GLP-1 and GIP,…
